Recursion Pharmaceuticals develops advanced technologies for drug discovery and development using machine learning and biology.
Recursion's physics-AI-chemistry-biology model stack, powered by 50 petabytes of proprietary cellular data, enables computable drug discovery with far fewer compounds per target, validated by half a billion dollars in big pharma partnerships and clinical results.